Jacobi Capital Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-445
Closed -$15K 1262
2020
Q2
$15K Hold
445
﹤0.01% 697
2020
Q1
$12K Hold
445
﹤0.01% 677
2019
Q4
$15K Hold
445
﹤0.01% 677
2019
Q3
$14K Hold
445
﹤0.01% 674
2019
Q2
$15K Hold
445
﹤0.01% 676
2019
Q1
$15K Hold
445
﹤0.01% 635
2018
Q4
$12K Hold
445
﹤0.01% 635
2018
Q3
$17K Buy
445
+100
+29% +$3.68K ﹤0.01% 602
2018
Q2
$12K Hold
345
﹤0.01% 686
2018
Q1
$11K Buy
+345
New +$11.7K ﹤0.01% 670

Other funds holding FFTY

Jacobi Capital Management's FFTY Position: Q3 2020 in Review

Jacobi Capital Management sold out of CapForce IBD 50 ETF (FFTY) in Q3 2020, closing a stake of 445 shares — an estimated $15K sold.

Jacobi Capital Management first reported a position in FFTY in Q1 2018 and held it in 10 quarters. The position peaked at $17K in Q3 2018. 61 funds tracked by Wall St. Rank hold FFTY as of Q3 2020.

  • Jacobi Capital Management reported no remaining CapForce IBD 50 ETF position as of Q3 2020 after selling out during the quarter.
  • Jacobi Capital Management sold 445 CapForce IBD 50 ETF shares in Q3 2020, an estimated $15K.
  • Jacobi Capital Management first reported a position in CapForce IBD 50 ETF in Q1 2018 and held it in 10 quarters.
  • Jacobi Capital Management's CapForce IBD 50 ETF position peaked at $17K in Q3 2018.
  • 61 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2020.

Based on Jacobi Capital Management's 13F filing for Q3 2020, filed 30 Oct 2020.